litlas
ログインアカウント作成

Sonia M. Davis

1990–2019 年に発表

50
論文数
20,121
被引用数
49
h 指数
50
i10 指数

被引用数

Sonia M. Davis の年別被引用数1991 年: 被引用 2 件1992 年: 被引用 5 件1993 年: 被引用 7 件1994 年: 被引用 6 件1995 年: 被引用 10 件1996 年: 被引用 6 件1997 年: 被引用 2 件1998 年: 被引用 6 件1999 年: 被引用 2 件2000 年: 被引用 18 件2001 年: 被引用 15 件2002 年: 被引用 35 件2003 年: 被引用 35 件2004 年: 被引用 31 件2005 年: 被引用 56 件2006 年: 被引用 185 件2007 年: 被引用 269 件2008 年: 被引用 322 件2009 年: 被引用 282 件2010 年: 被引用 306 件2011 年: 被引用 217 件2012 年: 被引用 204 件2013 年: 被引用 151 件2014 年: 被引用 141 件2015 年: 被引用 131 件2016 年: 被引用 122 件2017 年: 被引用 100 件2018 年: 被引用 136 件2019 年: 被引用 440 件2020 年: 被引用 358 件2021 年: 被引用 324 件2022 年: 被引用 226 件2023 年: 被引用 144 件2024 年: 被引用 251 件2025 年: 被引用 90 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,100 件、この内訳の 36.2%イギリス: 引用元論文 533 件、この内訳の 9.2%カナダ: 引用元論文 367 件、この内訳の 6.3%ドイツ: 引用元論文 286 件、この内訳の 4.9%オーストラリア: 引用元論文 225 件、この内訳の 3.9%中国: 引用元論文 213 件、この内訳の 3.7%イタリア: 引用元論文 169 件、この内訳の 2.9%オランダ: 引用元論文 144 件、この内訳の 2.5%スペイン: 引用元論文 140 件、この内訳の 2.4%フランス: 引用元論文 126 件、この内訳の 2.2%日本: 引用元論文 101 件、この内訳の 1.8%スイス: 引用元論文 100 件、この内訳の 1.7%
0%36.2%その他 22.3%

機関

分野

  • Medicine64.4%
  • Neuroscience16.7%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Psychology5.9%
  • Health Professions2.4%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • その他3.1%

トピック

  • Schizophrenia research and treatment13.7%
  • Treatment of Major Depression3.9%
  • Dementia and Cognitive Impairment Research3.8%
  • Tryptophan and brain disorders3.7%
  • Bipolar Disorder and Treatment3.1%
  • Mental Health and Psychiatry2.2%
  • その他69.6%

共著者

全論文

検索で開く
  1. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort

    著者: Rebecca F. Gottesman, Marilyn S. Albert, Álvaro Alonso, Laura H. Coker, Josef Coresh, Sonia M. Davis, Jennifer A. Deal, Guy M. McKhann, Thomas H. Mosley, A. Richey Sharrett, Andrea L.C. Schneider, B. Gwen Windham, Lisa Wruck, David S. Knopman - JAMA Neurology 2017 被引用: 633

  2. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    著者: Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao - New England Journal of Medicine 2005 被引用: 5,895

  3. Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial

    著者: A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, W. J. Burke, Mark Hyman Rapaport, John Zajecka, Andrew A. Nierenberg, Mustafa M. Husain, David Ginsberg, R.G. Cooke - Insecta mundi 2005 被引用: 686

  4. Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

    著者: Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, Sonia M. Davis, John Hsiao, M. Saleem Ismail, Barry D. Lebowitz, Constantine G. Lyketsos, J. Michael Ryan, T. Scott Stroup, David L. Sultzer, Daniel Weintraub, Jeffrey A. Lieberman - New England Journal of Medicine 2006 被引用: 1,198

  5. Gender differences in chronic major and double depression

    著者: Susan G. Kornstein, Alan F. Schatzberg, Michael E. Thase, Kimberly A. Yonkers, James P. McCullough, Gabor I. Keitner, Alan J. Gelenberg, Christine E. Ryan, Aleksandra Hess, Wilma Harrison, Sonia M. Davis, Martin B. Keller - Journal of Affective Disorders 2000 被引用: 501

  6. Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    著者: Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, for the CATIE Investigators - American Journal of Psychiatry 2006 被引用: 755

  7. Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study

    著者: A. John Rush, Harold A. Sackeïm, Lauren B. Marangell, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Phil Lavori, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, Linda L. Carpenter, Philip T. Ninan, Francisco Moreno, Thomas Schwartz, Charles R. Conway, Michael J. Burke, John J. Barry - Biological Psychiatry 2005 被引用: 395

  8. A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression

    著者: Mark S. George, A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Francisco Moreno, Barry R. Rittberg, David L. Dünner, Thomas Schwartz, Linda L. Carpenter, Michael J. Burke, Philip T. Ninan, Paul J. Goodnick - Biological Psychiatry 2005 被引用: 372

  9. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study

    著者: Jeffrey S. Hyams, Sonia M. Davis, David Mack, Brendan Boyle, Anne M. Griffiths, Neal S. LeLeiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel R. Rosh, Robert N. Baldassano, Ashish Patel, Marian Pfefferkorn, Anthony Otley, Melvin B. Heyman, Joshua D. Noe, Maria Oliva‐Hemker, Paul A. Rufo, Jennifer Strople, David Ziring, Stephen L. Guthery, Boris Sudel, Keith Benkov, Prateek Wali, Dedrick E. Moulton, Jonathan Evans, Michael D. Kappelman, Alison Marquis, Francisco Sylvester, Margaret H. Collins, Suresh Venkateswaran, Marla Dubinsky, Vin Tangpricha, Krista Spada, Ashley Britt, Bradley Saul, Nathan Gotman, Jessie Wang, José Serrano, Subra Kugathasan, Thomas Walters, Lee A. Denson - ˜The œLancet. Gastroenterology & hepatology 2017 被引用: 100

  10. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

    著者: Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff, Henry A. Nasrallah, Sonia M. Davis, Lisa Sullivan, Herbert Y. Meltzer, John Hsiao, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2005 被引用: 1,139

  11. Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression

    著者: Susan G. Kornstein, Alan F. Schatzberg, Michael E. Thase, Kimberly A. Yonkers, James P. McCullough, Gabor I. Keitner, Alan J. Gelenberg, Sonia M. Davis, Wilma Harrison, Martín Keller - American Journal of Psychiatry 2000 被引用: 707

  12. Cardiovascular health among diverse Hispanics/Latinos: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) results

    著者: Hector M. González, Wassim Tarraf, Carlos J. Rodríguez, Linda C. Gallo, Ralph L. Sacco, Gregory A. Talavera, Gerardo Heiss, Jorge R. Kizer, Rosalba Hernández, Sonia M. Davis, Neil Schneiderman, Martha L. Daviglus, Robert C. Kaplan - American Heart Journal 2016 被引用: 97

  13. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

    著者: Donald Goff, Lisa Sullivan, Joseph P. McEvoy, Jonathan M. Meyer, Henry A. Nasrallah, Gail L. Daumit, Steven Lamberti, Ralph B. D’Agostino, Thomas S. Stroup, Sonia M. Davis, Jeffrey A. Lieberman - Schizophrenia Research 2005 被引用: 531

  14. Neurocognitive Function Among Middle-aged and Older Hispanic/Latinos: Results from the Hispanic Community Health Study/Study of Latinos

    著者: Hector M. González, Wassim Tarraf, Natalia Gouskova, Linda C. Gallo, Frank J. Penedo, Sonia M. Davis, Richard B. Lipton, William Argüelles, James P. Choca, Diane Catellier, Thomas H. Mosley - Archives of Clinical Neuropsychology 2014 被引用: 118

  15. MSQ: Migraine-Specific Quality-of-Life Questionnaire

    著者: Priti Jhingran, Sonia M. Davis, Lisa M. LaVange, David W. Miller, Ronald W. Helms - PharmacoEconomics 1998 被引用: 95

  16. Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial

    著者: David L. Sultzer, Sonia M. Davis, Pierre N. Tariot, Karen Dagerman, Barry D. Lebowitz, Constantine G. Lyketsos, Robert A. Rosenheck, John Hsiao, Jeffrey A. Lieberman, Lon S. Schneider, CATIE-AD Study Group - American Journal of Psychiatry 2008 被引用: 317

  17. Physical Activity Levels in U.S. Latino/Hispanic Adults

    著者: Elva M. Arredondo, Daniela Sotres‐Alvarez, Mark Stoutenberg, Sonia M. Davis, Noé C. Crespo, Mercedes R. Carnethon, Sheila F. Castañeda, Carmen R. Isasi, Rebeca A. Espinoza, Martha L. Daviglus, Lilian G. Perez, Kelly R. Evenson - American Journal of Preventive Medicine 2015 被引用: 168

  18. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study

    著者: Jennifer A. Deal, Marilyn S. Albert, Michelle Arnold, Shrikant I. Bangdiwala, Theresa H. Chisolm, Sonia M. Davis, Ann Clock Eddins, Nancy W. Glynn, Adele M. Goman, Melissa Minotti, Thomas Mosley, George W. Rebok, Nicholas S. Reed, Elizabeth Rodgers, Victoria A. Sanchez, A. Richey Sharrett, Josef Coresh, Frank R. Lin - Alzheimer s & Dementia Translational Research & Clinical Interventions 2017 被引用: 106

  19. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline

    著者: Henry A. Nasrallah, Jonathan M. Meyer, Donald Goff, Joseph P. McEvoy, Sonia M. Davis, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2006 被引用: 558

  20. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

    著者: Richard S.E. Keefe, Robert M. Bilder, Philip D. Harvey, Sonia M. Davis, Barton W. Palmer, James M. Gold, Herbert Y. Meltzer, Michael F. Green, Del D. Miller, José M. Cañive, Lawrence Adler, Theo C. Manschreck, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Trina M. Walker, T. Scott Stroup, Joseph P. McEvoy, Jeffrey A. Lieberman - Neuropsychopharmacology 2006 被引用: 469

  21. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

    著者: Jonathan M. Meyer, Vicki G. Davis, Donald Goff, Joseph P. McEvoy, Henry A. Nasrallah, Sonia M. Davis, Robert A. Rosenheck, Gail L. Daumit, John Hsiao, Marvin S. Swartz, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2008 被引用: 287

  22. Machismo, marianismo, and negative cognitive-emotional factors: Findings from the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study.

    著者: Alicia Núñez, Patricia González, Gregory A. Talavera, Lisa Sánchez-Johnsen, Scott C. Roesch, Sonia M. Davis, William Argüelles, Veronica Y. Womack, Natania W. Ostrovsky, Lizette Ojeda, Frank J. Penedo, Linda C. Gallo - Journal of Latina/o Psychology 2015 被引用: 274

  23. Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial

    著者: Del D. Miller, Joseph P. McEvoy, Sonia M. Davis, Stanley N. Caroff, Bruce L. Saltz, Miranda Chakos, Marvin S. Swartz, Richard S.E. Keefe, Robert A. Rosenheck, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2005 被引用: 156

  24. Results of phase 3 of the CATIE schizophrenia trial

    著者: T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Sonia M. Davis, Marvin S. Swartz, Richard S.E. Keefe, Alexander L. Miller, Robert A. Rosenheck, John Hsiao - Schizophrenia Research 2008 被引用: 142